During the past decade, Robert Scott MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Robert Scott MD" are "HIV Infections" (6 trials). Many other conditions were trialed in "Robert Scott MD" in a lesser frequency.

Most popular intervention types in "Robert Scott MD" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Abacavir sulfate" (2 trials), "Lamivudine/Zidovudine" (2 trials), "Nelfinavir mesylate" (2 trials), "Stavudine" (2 trials) and "Abacavir sulfate, Lamivudine and Zidovudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Robert Scott MD" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Robert Scott MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Robert Scott MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Robert Scott MD, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".